Border to Coast Pensions Partnership Ltd Buys 48,437 Shares of Danaher Corporation $DHR

Border to Coast Pensions Partnership Ltd increased its stake in shares of Danaher Corporation (NYSE:DHR) by 31.1% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 204,350 shares of the conglomerate’s stock after acquiring an additional 48,437 shares during the period. Border to Coast Pensions Partnership Ltd’s holdings in Danaher were worth $40,514,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of DHR. Tyche Wealth Partners LLC acquired a new position in Danaher in the 3rd quarter valued at about $462,000. Ceredex Value Advisors LLC lifted its holdings in shares of Danaher by 1.6% during the second quarter. Ceredex Value Advisors LLC now owns 249,377 shares of the conglomerate’s stock worth $49,262,000 after buying an additional 3,862 shares in the last quarter. Weitz Investment Management Inc. boosted its position in shares of Danaher by 6.1% in the second quarter. Weitz Investment Management Inc. now owns 526,950 shares of the conglomerate’s stock valued at $104,094,000 after acquiring an additional 30,300 shares during the period. Lockheed Martin Investment Management Co. grew its stake in shares of Danaher by 49.4% in the third quarter. Lockheed Martin Investment Management Co. now owns 25,340 shares of the conglomerate’s stock valued at $5,024,000 after acquiring an additional 8,380 shares in the last quarter. Finally, Nvwm LLC increased its position in Danaher by 20.4% during the second quarter. Nvwm LLC now owns 7,093 shares of the conglomerate’s stock worth $1,401,000 after acquiring an additional 1,204 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have commented on DHR. Argus set a $265.00 price objective on Danaher in a research note on Wednesday, January 14th. HSBC boosted their price objective on shares of Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a research report on Monday, December 1st. Jefferies Financial Group upped their price objective on Danaher from $255.00 to $265.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Evercore ISI reiterated an “outperform” rating and set a $254.00 price objective on shares of Danaher in a research report on Wednesday, January 28th. Finally, Guggenheim boosted their target price on shares of Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a research note on Friday, January 2nd. Twenty investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $252.32.

Danaher Stock Performance

Shares of Danaher stock opened at $219.31 on Thursday. The business has a 50-day moving average price of $230.07 and a two-hundred day moving average price of $214.68. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. The company has a market cap of $154.91 billion, a P/E ratio of 43.51, a PEG ratio of 2.93 and a beta of 0.91.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 28th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. During the same period in the previous year, the business earned $2.14 EPS. The firm’s revenue was up 4.6% compared to the same quarter last year. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. As a group, analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Friday, December 26th. Danaher’s payout ratio is presently 25.40%.

Insider Buying and Selling at Danaher

In other Danaher news, Director Teri List sold 3,298 shares of the firm’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the transaction, the director directly owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. This trade represents a 13.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total value of $4,773,952.48. Following the transaction, the senior vice president owned 14,553 shares of the company’s stock, valued at $3,190,454.19. This trade represents a 59.94% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 30,248 shares of company stock valued at $6,609,663. Company insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.